Jazz Pharmaceuticals Announces U.S. FDA Approval of Ziihera for the Treatment of Adults with Previously Treated, Unresectable or Metastatic HER2-positive Biliary Tract Cancer
| JAZZ Stock | USD 119.24 2.42 2.07% |
Slightly above 55% of Jazz Pharmaceuticals' investors are presently thinking to get in. The analysis of overall sentiment of trading Jazz Pharmaceuticals PLC stock suggests that some investors are interested at this time. Jazz Pharmaceuticals' investing sentiment can be driven by a variety of factors including economic data, Jazz Pharmaceuticals' earnings reports, geopolitical events, and overall market trends.
Jazz |
Jazz Pharmaceuticals plc today announced the U.S. Food and Drug Administration accelerated approval of Ziihera 50mgmL for injection for intravenous use for the treatment of adults with previously treated, unresectable or metastatic HER2-positive biliary tract cancer , as detected by an FDA-approved test.1 Ziihera was approved under accelerated approval based on a 52 percent objective response rate and a median duration of response of 1
Read at finance.yahoo.com
 |
Jazz Pharmaceuticals Fundamental Analysis
We analyze Jazz Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Jazz Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Jazz Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Market Capitalization
Market Capitalization Comparative Analysis
Jazz Pharmaceuticals is currently under evaluation in market capitalization category among its peers. Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Jazz Pharmaceuticals PLC Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Jazz Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Jazz Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Jazz Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Jazz Pharmaceuticals Related Equities
| CHWY | Chewy | 5.10 | ||||
| LOMLF | Lion One | 4.76 | ||||
| CGAU | Centerra Gold | 0.66 | ||||
| EYE | National Vision | 0.53 | ||||
| CENX | Century Aluminum | 0.52 | ||||
| TBBB | BBB Foods | 0.15 | ||||
| CPNG | Coupang LLC | 0.91 | ||||
| EGO | Eldorado Gold | 0.92 |
Additional Tools for Jazz Stock Analysis
When running Jazz Pharmaceuticals' price analysis, check to measure Jazz Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jazz Pharmaceuticals is operating at the current time. Most of Jazz Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Jazz Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jazz Pharmaceuticals' price. Additionally, you may evaluate how the addition of Jazz Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.